Kenneth Walter Bair - Net Worth and Insider Trading

Kenneth Walter Bair Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth Walter Bair owns 1 companies in total, including CASI Pharmaceuticals Inc () .

Click here to see the complete history of Kenneth Walter Bair’s form 4 insider trades.

Insider Ownership Summary of Kenneth Walter Bair

Ticker Comapny Transaction Date Type of Owner
CASI Pharmaceuticals Inc 2007-10-16 SVP & Research and Development

Kenneth Walter Bair Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kenneth Walter Bair Ownership Network

Ownership Network List of Kenneth Walter Bair

No Data

Ownership Network Relation of Kenneth Walter Bair


Kenneth Walter Bair Owned Company Details

What does CASI Pharmaceuticals Inc do?

Who are the key executives at CASI Pharmaceuticals Inc?

Kenneth Walter Bair is the SVP & Research and Development of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .

CASI Pharmaceuticals Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CASI Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CASI Pharmaceuticals Inc Insider Transactions

No Available Data

Kenneth Walter Bair Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth Walter Bair. You might contact Kenneth Walter Bair via mailing address: Entremed, Inc., 9640 Medical Center Drive, Rockville Md 20850.

Discussions on Kenneth Walter Bair

No discussions yet.